Back to search

Article

Choice of antibody is critical for specific and sensitive detection of androgen receptor splice variant-7 in circulating tumor cells

2022-06-10

Abstract excerpt

<h4>Background: </h4> Androgen receptor variant 7 (AR-V7) is an important biomarker to guide treatment options for castration-resistant prostate cancer (CRPC) patients. Its detectability in circulating tumour cells (CTCs) opens non-invasive diagnostic avenues. While detectable at the transcript level, AR-V7 protein detection in CTCs may add additional information and clinical relevance. Aims The aim of this study...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
02886638-0dc8-5387-ad4e-f5f8d58030df
DOI
10.21203/rs.3.rs-1602818/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Choice of antibody is critical for specific and sensitive detection of androgen receptor splice variant-7 in circulating tumor cellsDOI 10.21203/rs.3.rs-1602818/v2
Select a neighboring publication to make it the new centre.